GRCE

Grace Therapeutics, Inc

2.350

-1.960-45.48%

Pre Market: 2.280 -0.070 -2.98%07:46 04/24 EDT

Daily

Weekly

Monthly

Quarterly

Yearly

OPEN/PREV CLOSE4.350/4.310

TODAY RANGE1.790-4.640

VOL13.16K

MARKET CAP36.36M

52 WEEK RANGE1.790-5.18

AVG VOL (3M)607.77K

% TURNOVER42.31%

TURNOVER0

P/E (TTM)-6.5151

% RANGE66.12%

EPS(TTM)-0.3607

P/E(FORWARD)-0.3727

P/B0.5604

BVPS4.194

DIVIDEND--

P/S33.92

BETA--

DIV YIELD0.00%

FREE FLOAT MKT CAP24.95M

SHARES OUTSTANDING15.47M

NEXT EARNINGS06/26-07/02

FREE FLOAT10.62M

LOT SIZE1

EX-DATE07/10/2023

Feeds

News

Press Releases

Financial Reports

Profile

Same Industry

Name/Symbol

Change%

Price

GRCE

Regeneron Pharmaceuticals

REGN

+0.61%

750.57

GRDX

BIONTECH

BNTX

+0.78%

102.92

United Therapeutics Corp.

UTHR

-1.87%

577.41

Vertex Pharmaceuticals Inc

VRTX

+1.27%

441.20

SIGA

Moderna

MRNA

-1.76%

53.72

Charles Riv Labs Intl Inc

CRL

+3.92%

183.88

MEDP

Talphera Inc

TLPH

-0.79%

0.8026

ICON PLC

ICLR

+3.55%

119.68

China Biologic

CBPO

0.00%

119.99

Iqvia Hldgs Inc

IQV

+2.62%

176.46

MOLECULAR PARTNERS AG

MOLN

+0.60%

4.205

ARCT

Gilead Sciences Inc

GILD

-0.66%

137.64

PRA Health

PRAH

0.00%

165.21

Incyte Corp

INCY

-1.31%

95.47

Aptevo Therapeutics Inc

APVO

-1.52%

5.20

Biospecifics

BSTC

+0.15%

88.53

No content on the Webull website shall be considered a recommendation or solicitation for the purchase or sale of securities, options or other investment products. All information and data on the website is for reference only and no historical data shall be considered as the basis for judging future trends.